Immune responses against tumour-associated antigen-derived cytotoxic T lymphocyte epitopes in cholangiocarcinoma patients.

Akihiko Kida Eishiro MizukoshiToshikatsu TamaiTakeshi TerashimaMasaaki KitaharaKuniaki AraiTatsuya YamashitaKazumi FushimiMasao HondaShuichi Kaneko

Published in: Liver international : official journal of the International Association for the Study of the Liver (2018)

These results demonstrated several TAAs may be promising for immunotherapy for cholangiocarcinoma, and patients with high lymphocyte counts may benefit more from immunotherapy.

Keyphrases

immune response
peripheral blood
end stage renal disease
ejection fraction
prognostic factors
dendritic cells